We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.57%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$578B
AUM Growth
+$59.6B
Cap. Flow
+$35.2B
Cap. Flow %
6.08%
Top 10 Hldgs %
31.21%
Holding
15,826
New
1,745
Increased
6,428
Reduced
6,082
Closed
1,423

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$830M
2
UNH icon
UnitedHealth
UNH
+$769M
3
AJG icon
Arthur J. Gallagher & Co
AJG
+$691M
4
AMZN icon
Amazon
AMZN
+$654M
5
BAC icon
Bank of America
BAC
+$634M

Sector Composition

Rank Sector Weight
1 Healthcare 3.13%
2 Technology 2.97%
3 Financials 2.19%
4 Consumer Discretionary 2.09%
5 Industrials 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGI
14351
Somnigroup International
SGI
$14B
$57 ﹤0.01%
1
-13,073
-100% -$698K
ELEV
14352
CALL
DELISTED
Elevation Oncology
ELEV
$56 ﹤0.01%
100
-600
-86% -$354
XBIT icon
14353
XBiotech
XBIT
$71.6M
$51 ﹤0.01%
+13
New +$89
SBEV icon
14354
PUT
Splash Beverage Group
SBEV
$2.53M
$48 ﹤0.01%
2
+1
+100% +$33
KLRS
14355
PUT
Kalaris Therapeutics
KLRS
$97.8M
$42 ﹤0.01%
4
-5
-56% -$76
OMGA
14356
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$37 ﹤0.01%
49
GOEV
14357
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$35 ﹤0.01%
25
-2,464
-99% -$26.8K
FWRD icon
14358
Forward Air
FWRD
$663M
$32 ﹤0.01%
1
-300
-100% -$10.5K
MCRB icon
14359
Seres Therapeutics
MCRB
$45.5M
$26 ﹤0.01%
+2
New +$33
KNDI
14360
Kandi Technologies Group
KNDI
$63M
$25 ﹤0.01%
21
+18
+600% +$23
FNUC
14361
Frontier Nuclear and Minerals Inc
FNUC
$49M
$19 ﹤0.01%
+2
New +$9
GTE icon
14362
Gran Tierra Energy
GTE
$333M
$14 ﹤0.01%
2
AZUL
14363
DELISTED
Azul
AZUL
$13 ﹤0.01%
8
-3,062
-100% -$7.98K
CTXR icon
14364
Citius Pharmaceuticals
CTXR
$20.3M
$4 ﹤0.01%
+1
New +$7
AAPU icon
14365
Direxion Daily AAPL Bull 2X ETF
AAPU
$187M
-50,489
Closed -$1.89M
ABTS icon
14366
CALL
Abits Group
ABTS
$3.91M
-133
Closed -$1.02K
ABTS icon
14367
Abits Group
ABTS
$3.91M
-997
Closed -$7.66K
ACES icon
14368
ALPS Clean Energy ETF
ACES
$125M
-7,843
Closed -$231K
ACIU icon
14369
PUT
AC Immune
ACIU
$249M
-100
Closed -$378
ADME icon
14370
Aptus Behavioral Momentum ETF
ADME
$308M
-6,592
Closed -$305K
ADUS icon
14371
Addus HomeCare
ADUS
$2.18B
-34,329
Closed -$4.34M
ADV icon
14372
CALL
Advantage Solutions
ADV
$422M
-144
Closed -$12.3K
ADV icon
14373
Advantage Solutions
ADV
$422M
-619
Closed -$53.1K
ADV icon
14374
PUT
Advantage Solutions
ADV
$422M
-12
Closed -$1.03K
AEHL icon
14375
Antelope Enterprise Holdings
AEHL
$5.01M
-5
Closed -$15.2K

Similar funds

Ken Griffin's Q4 2024 Portfolio in Review

As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.

  • Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
  • Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
  • Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
  • Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
  • Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
  • Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
  • Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.